Managed Account Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$2.92M Buy
26,910
+8,487
+46% +$1.06M ﹤0.01% 1684
2015
Q1
$2.33M Buy
18,423
+1,842
+11% +$240K ﹤0.01% 1778
2014
Q4
$2.11M Buy
16,581
+6,978
+73% +$968K ﹤0.01% 1793
2014
Q3
$1.29M Buy
+9,603
New +$1.34M ﹤0.01% 1971

Other funds holding TNDM

Managed Account Advisors's TNDM Position: Q2 2015 in Review

Managed Account Advisors increased its Tandem Diabetes Care (TNDM) stake by 46% in Q2 2015, buying an estimated $1.06M and bringing the position to 26,910 shares worth $2.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1684.

Managed Account Advisors first reported a position in TNDM in Q3 2014 and has held it in 4 quarters since. 87 funds tracked by Wall St. Rank hold TNDM as of Q2 2015.

  • Managed Account Advisors held 26,910 shares of Tandem Diabetes Care worth $2.92M as of Q2 2015.
  • Managed Account Advisors bought 8,487 Tandem Diabetes Care shares in Q2 2015, an estimated $1.06M.
  • Tandem Diabetes Care made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1684 holding.
  • Managed Account Advisors first reported a position in Tandem Diabetes Care in Q3 2014 and has held it in 4 quarters since.
  • 87 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.